How a 503A pharmacy should qualify a peptide supplier
Most peptide supplier problems show up during a board inspection, not at the time of purchase. The inspector asks for the supplier qualification file on your semaglutide or BPC-157 and the pharmacy has a CoA from a website and nothing else. Here is what the file should contain, and what to ask before the first order.
Ask for the documents first, pricing second
A legitimate bulk supplier can send you, before you spend a dollar: a lot-specific certificate of analysis with HPLC purity and LC-MS identity, a supplier qualification packet describing the manufacturing site and quality system, a sample pedigree or transaction statement, and a safety data sheet. If any of those take more than a day to produce, that tells you how the recall call will go.
Read the CoA like an inspector
Look for the lot number on the CoA to match the vial label, a named analytical method (not just "purity 99%"), a chromatogram or a reference to one, net peptide content on bulk API, and endotoxin and sterility results on anything labeled injectable-grade. A CoA with no method, no lot and no date is a marketing sheet.
Confirm where it was actually made
"US-based" and "US-manufactured" are not the same claim. Ask directly whether the peptide was synthesized and lyophilized in the United States or imported in bulk and relabeled. Either can be lawful depending on your state and the substance, but you need to know which one you're documenting.
Check that the supplier verifies you
A supplier that will sell to anyone with a credit card is a supplier whose product is also sitting in consumer channels. That is a compliance exposure for you as well as a quality signal. Expect to be asked for your pharmacy license and, where applicable, DEA registration, and expect annual re-verification.
Bulk-substance eligibility is your call, not theirs
Under FDCA §503A, the pharmacy remains responsible for whether a given bulk substance may be compounded in its state. A good supplier will say this plainly and will not promise that a product is "503A approved." No such thing exists.
Red flags
- Retail pricing visible to the public, or a consumer checkout on the same site.
- Efficacy or treatment claims in the product listing.
- CoAs that are identical across lots, or issued by an unnamed lab.
- Reluctance to put recall and lot-trace procedures in writing.
- Payment only by wire to an individual or a crypto wallet.
We built our quality program around this list because it is the list our pharmacy customers get asked for. If you want a sample packet to compare against your current supplier, request one.